Morbidity in New Zealand pesticide producers exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). 2018

Andrea 't Mannetje, and Amanda Eng, and Chris Walls, and Evan Dryson, and Jeroen Douwes, and Pier Bertazzi, and Simon Ryder-Lewis, and David Scott, and Collin Brooks, and Dave McLean, and Soo Cheng, and Neil Pearce
Centre for Public Health Research, Massey University, PO Box 756, Wellington 6021, New Zealand. Electronic address: a.mannetje@massey.ac.nz.

To conduct a cross-sectional morbidity survey among 245 former employees of a pesticide production plant exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in New Zealand. Demographic factors and health information were collected in face-to-face interviews. TCDD, lipids, thyroid hormones, glucose and immunoglobulin G (IgG) were determined in non-fasting blood. For 111 participants, a neurological examination was conducted. Associations between health outcomes and working in a TCDD exposed job (prevalence 49%) and serum TCDD concentration≥10pg/g lipid (18%) were assessed using logistic regression whilst controlling for age, gender, smoking, body mass index and ethnicity. Diabetes was more common in those who had worked in TCDD exposed jobs (OR 4.0, 95%CI 1.0-15.4) and in those with serum TCDD ≥10pg/g (OR 3.1, 95%CI 0.9-10.7). Non-fasting glucose levels >6.6mmol/l were more common in those with TCDD exposed jobs (OR 3.6, 95%CI 1.0-12.9), as were serum free thyroxine 4<12.8pmol/l (OR 4.5, 95%CI 1.4-14.4), triglycerides >1.7mmol/l (OR 2.5, 95%CI 1.1-5.7) and high density lipoprotein cholesterol (HDL) <1mmol/l (OR 4.0, 95%CI 1.2-13.2). IgG was negatively associated with TCDD (linear regression p=0.05). The neurological examination revealed a higher frequency of abnormal reflexes in those with serum TCDD ≥10pg/g (OR 4.8, 95%CI 1.1-21.0). In this occupationally exposed population, TCDD was associated with an increased risk of diabetes and a range of subclinical responses in multiple systems (peripheral nervous system, immune system, thyroid hormones and lipid metabolism), several decades after last exposure. These results need to be interpreted with caution due to the small study size and the cross-sectional nature of the study.

UI MeSH Term Description Entries
D007407 Interviews as Topic Works about conversations with an individual or individuals held in order to obtain information about their background and other personal biographical data, their attitudes and opinions, etc. It includes works about school admission or job interviews. Group Interviews,Interviewers,Interviews, Telephone,Oral History as Topic,Group Interview,Interview, Group,Interview, Telephone,Interviewer,Interviews, Group,Telephone Interview,Telephone Interviews
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009520 New Zealand A group of islands in the southwest Pacific. Its capital is Wellington. It was discovered by the Dutch explorer Abel Tasman in 1642 and circumnavigated by Cook in 1769. Colonized in 1840 by the New Zealand Company, it became a British crown colony in 1840 until 1907 when colonial status was terminated. New Zealand is a partly anglicized form of the original Dutch name Nieuw Zeeland, new sea land, possibly with reference to the Dutch province of Zeeland. (From Webster's New Geographical Dictionary, 1988, p842 & Room, Brewer's Dictionary of Names, 1992, p378)
D009784 Occupational Diseases Diseases caused by factors involved in one's employment. Diseases, Occupational,Occupational Illnesses,Disease, Occupational,Illnesse, Occupational,Illnesses, Occupational,Occupational Disease,Occupational Illnesse
D010575 Pesticides Chemicals used to destroy pests of any sort. The concept includes fungicides (FUNGICIDES, INDUSTRIAL); INSECTICIDES; RODENTICIDES; etc. Pesticide
D002617 Chemical Industry The aggregate enterprise of manufacturing and technically producing chemicals. (From Random House Unabridged Dictionary, 2d ed) Industry, Chemical,Chemical Industries,Industries, Chemical
D003430 Cross-Sectional Studies Studies in which the presence or absence of disease or other health-related variables are determined in each member of the study population or in a representative sample at one particular time. This contrasts with LONGITUDINAL STUDIES which are followed over a period of time. Disease Frequency Surveys,Prevalence Studies,Analysis, Cross-Sectional,Cross Sectional Analysis,Cross-Sectional Survey,Surveys, Disease Frequency,Analyses, Cross Sectional,Analyses, Cross-Sectional,Analysis, Cross Sectional,Cross Sectional Analyses,Cross Sectional Studies,Cross Sectional Survey,Cross-Sectional Analyses,Cross-Sectional Analysis,Cross-Sectional Study,Cross-Sectional Surveys,Disease Frequency Survey,Prevalence Study,Studies, Cross-Sectional,Studies, Prevalence,Study, Cross-Sectional,Study, Prevalence,Survey, Cross-Sectional,Survey, Disease Frequency,Surveys, Cross-Sectional
D003924 Diabetes Mellitus, Type 2 A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent (NIDDM). It is characterized initially by INSULIN RESISTANCE and HYPERINSULINEMIA; and eventually by GLUCOSE INTOLERANCE; HYPERGLYCEMIA; and overt diabetes. Type II diabetes mellitus is no longer considered a disease exclusively found in adults. Patients seldom develop KETOSIS but often exhibit OBESITY. Diabetes Mellitus, Adult-Onset,Diabetes Mellitus, Ketosis-Resistant,Diabetes Mellitus, Maturity-Onset,Diabetes Mellitus, Non-Insulin-Dependent,Diabetes Mellitus, Slow-Onset,Diabetes Mellitus, Stable,MODY,Maturity-Onset Diabetes Mellitus,NIDDM,Diabetes Mellitus, Non Insulin Dependent,Diabetes Mellitus, Noninsulin Dependent,Diabetes Mellitus, Noninsulin-Dependent,Diabetes Mellitus, Type II,Maturity-Onset Diabetes,Noninsulin-Dependent Diabetes Mellitus,Type 2 Diabetes,Type 2 Diabetes Mellitus,Adult-Onset Diabetes Mellitus,Diabetes Mellitus, Adult Onset,Diabetes Mellitus, Ketosis Resistant,Diabetes Mellitus, Maturity Onset,Diabetes Mellitus, Slow Onset,Diabetes, Maturity-Onset,Diabetes, Type 2,Ketosis-Resistant Diabetes Mellitus,Maturity Onset Diabetes,Maturity Onset Diabetes Mellitus,Non-Insulin-Dependent Diabetes Mellitus,Noninsulin Dependent Diabetes Mellitus,Slow-Onset Diabetes Mellitus,Stable Diabetes Mellitus
D005260 Female Females

Related Publications

Andrea 't Mannetje, and Amanda Eng, and Chris Walls, and Evan Dryson, and Jeroen Douwes, and Pier Bertazzi, and Simon Ryder-Lewis, and David Scott, and Collin Brooks, and Dave McLean, and Soo Cheng, and Neil Pearce
January 2004, Report on carcinogens : carcinogen profiles,
Andrea 't Mannetje, and Amanda Eng, and Chris Walls, and Evan Dryson, and Jeroen Douwes, and Pier Bertazzi, and Simon Ryder-Lewis, and David Scott, and Collin Brooks, and Dave McLean, and Soo Cheng, and Neil Pearce
January 2002, Report on carcinogens : carcinogen profiles,
Andrea 't Mannetje, and Amanda Eng, and Chris Walls, and Evan Dryson, and Jeroen Douwes, and Pier Bertazzi, and Simon Ryder-Lewis, and David Scott, and Collin Brooks, and Dave McLean, and Soo Cheng, and Neil Pearce
January 1989, Neurotoxicology and teratology,
Andrea 't Mannetje, and Amanda Eng, and Chris Walls, and Evan Dryson, and Jeroen Douwes, and Pier Bertazzi, and Simon Ryder-Lewis, and David Scott, and Collin Brooks, and Dave McLean, and Soo Cheng, and Neil Pearce
August 1980, Journal of occupational medicine. : official publication of the Industrial Medical Association,
Andrea 't Mannetje, and Amanda Eng, and Chris Walls, and Evan Dryson, and Jeroen Douwes, and Pier Bertazzi, and Simon Ryder-Lewis, and David Scott, and Collin Brooks, and Dave McLean, and Soo Cheng, and Neil Pearce
January 2006, Reviews on environmental health,
Andrea 't Mannetje, and Amanda Eng, and Chris Walls, and Evan Dryson, and Jeroen Douwes, and Pier Bertazzi, and Simon Ryder-Lewis, and David Scott, and Collin Brooks, and Dave McLean, and Soo Cheng, and Neil Pearce
January 2012, Frontiers in oncology,
Andrea 't Mannetje, and Amanda Eng, and Chris Walls, and Evan Dryson, and Jeroen Douwes, and Pier Bertazzi, and Simon Ryder-Lewis, and David Scott, and Collin Brooks, and Dave McLean, and Soo Cheng, and Neil Pearce
October 1985, Toxicology and applied pharmacology,
Andrea 't Mannetje, and Amanda Eng, and Chris Walls, and Evan Dryson, and Jeroen Douwes, and Pier Bertazzi, and Simon Ryder-Lewis, and David Scott, and Collin Brooks, and Dave McLean, and Soo Cheng, and Neil Pearce
August 2013, Environmental and molecular mutagenesis,
Andrea 't Mannetje, and Amanda Eng, and Chris Walls, and Evan Dryson, and Jeroen Douwes, and Pier Bertazzi, and Simon Ryder-Lewis, and David Scott, and Collin Brooks, and Dave McLean, and Soo Cheng, and Neil Pearce
January 1985, International journal of immunopharmacology,
Andrea 't Mannetje, and Amanda Eng, and Chris Walls, and Evan Dryson, and Jeroen Douwes, and Pier Bertazzi, and Simon Ryder-Lewis, and David Scott, and Collin Brooks, and Dave McLean, and Soo Cheng, and Neil Pearce
November 2012, Occupational and environmental medicine,
Copied contents to your clipboard!